期刊文献+

亚降压剂量雷米普利预防高血压心肌肥厚的机制 被引量:2

Mechanism involved in the prevention of sub hypotensive dose of ramipril on hypertensive cardiac hypertrophy of rat
下载PDF
导出
摘要 目的 探讨亚降压剂量雷米普利的抗氧化作用对其抗高血压心肌肥厚作用的影响。方法 采用腹主动脉缩窄法制备大鼠高血压心肌肥厚模型。观察一氧化氮合酶抑制剂NL精氨酸(6mg·kg-1·d-1)和VitE(200U·d-1)对雷米普利(100μg·kg-1·d-1)抗心肌肥厚的影响,以及心肌超氧化物歧化酶(SOD)、一氧化氮代谢物(NO2-)等指标的变化。结果 给予雷米普利后8wk,与对照组比较心肌肥厚减轻而血压无明显降低,NO2-含量和SOD活性明显提高,脂质过氧化物减少。VitE能增强上述大部分作用,而NL精氨酸能逆转此增强作用。结论 亚降压剂量雷米普利有抗心肌肥厚的作用,VitE对此有增强作用,其机制与增强心肌抗氧化能力有关。 Aim To examine the role of antioxidant effect of subhypotensive dose of ACE inhibitor ramipril in its anti hypertrophic effect in rat myocardium. METHODS Model of hypertension induced myocardial hypertrophy of rat was reproduced by coarctation of abdominal aorta. The effects of nitric oxide (NO) synthase inhibitor N L arginine (6 mg·kg -1 ·d -1 ) and Vitamin E(200 U·d -1 ) on cardiac hypertrophy were examined. The change of superoxide dismutase (SOD) and NO production (assayed as NO 2 -) were monitored. RESULTS The myocardial hypertrophy was effectively prevented under hypertensive condition after treatment with ramipril for 8 week, while SOD activity and NO 2 - content were significantly increased and lipid peroxidation was significantly attenuated. Vitamin E enhanced ramipril effect and N L arginine reversed its benficail effects. CONCLUSION These data showed that sub hypotensive dose of ramipril and in combination with vitamin E enhances myocardial antioxidative capability and NO release, which plays an important role in the mechanism of action involved in their antihypertensive cardiac hypertrophic effects.
出处 《中国药理学通报》 CAS CSCD 北大核心 1999年第6期531-533,共3页 Chinese Pharmacological Bulletin
关键词 高血压 心肌肥厚 雷米普利 药物疗法 hypertension cardiac hypertrophy Ramipril vitamin E nitric oxide
  • 相关文献

参考文献1

二级参考文献5

  • 1Glennon PE, Sugden PH, Poole-Wilson PA. Cellular mechanisms of cardiac hypertrophy [J]. Br Heart J,1995, 73:496-499.
  • 2Loscalon J, Welch G. Nitric oxide and its role in the cardiovascular system[J]. Pro in Cardiovas Dis, 1995, 38:87-104.
  • 3Tsukada T, Yokoyam K, Arai T, et al. Evidence of association of the Enos gene polymorphism with plasma NO metabolite levels in humans [J]. Biochem Biophys Res Commun, 1998, 245 : 190-193.
  • 4Yokoyama K, Tsukada T, Nakayama M, et al. An intron 4 gene polymorphism in endothelial cell nitric oxide synthase might modulate volume-dependent hypertension in patients on hemodialysis [J]. Nephron, 2000,85(3):232-237.
  • 5黄惠彬,林丽香,陈鸣钦.内皮型一氧化氮合酶基因多态性与原发性高血压、2型糖尿病的关系[J].中华内分泌代谢杂志,2002,18(1):16-19. 被引量:24

共引文献1

同被引文献8

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部